Printer Friendly

BIODYNAMICS REPORTS RECORD 2ND QUARTER SALES AND EARNINGS

 BIODYNAMICS REPORTS RECORD 2ND QUARTER SALES AND EARNINGS
 TAMPA, Fla., June 17 /PRNewswire/ -- Biodynamics International, Inc.


(NASDAQ: BDYN) today reported record revenues for the second quarter ended May 31, 1992 of $1,790,432, increased 45 percent from revenues of $1,232,473 for the comparable period in 1991. Net earnings for the period were $244,601 or $0.036 per share, compared to second quarter 1991 earnings of $95,793 or $0.015 per share.
 Net earnings for the six months ended May 31, 1992 were $361,136 or $0.054 per share, up from $86,001, or $0.013 per share for the first six months of 1991. Revenues for the current six months period totaled $2,898,153, an increase of 52 percent compared to $1,905,779 reported for the comparable 1991 period.
 Increased sales and higher net profit margins, as well as two recently concluded private placements, have improved the company's financial condition significantly. The company's working capital ratio at May 31, 1992 was 4.5, compared to 1.92 at Nov. 30, 1991.
 John V. Hargiss, president and chief executive officer, commenting on mid-year results said, "Increased revenues are primarily attributable to the accelerating acceptance of the company's processed tissue allografts by neurosurgeons and orthopedic surgeons. Our improved profit margins are the results of a combination of the higher level of sales and our continuing efforts to control costs."
 Biodynamics International, Inc. provides specialty surgical products to the neurosurgical, orthopedic, cardiovascular, plastic and reconstructive specialties. The company is a Florida corporation with its executive offices in Tampa, Fla.
 BIODYNAMICS INTERNATIONAL, INC.
 STATEMENT OF OPERATIONS
 (Unaudited)
 Three Months Ended
 May 31,
 1992 1991
 REVENUES $1,790,432 $1,232,473
 Operating income before taxes 316,389 146,098
 Equity in (loss) of joint venture (67,558) (50,305)
 Income (loss) from operations before
 income tax and extraordinary item 248,831 95,793
 Income taxes (84,603) (32,570)
 Income before extraordinary item 164,228 63,323
 Extraordinary item: tax benefit of
 net operating loss carryforward 80,373 32,570
 NET INCOME $244,601 $95,793
 Earnings per share 0.036 0.015
 Weighted Average common
 shares outstanding 6,762,135 6,461,148
 Six Months Ended
 May 31,
 1992 1991
 REVENUES $2,898,153 $1,905,779
 Operating income before taxes 464,099 156,541
 Equity in (loss) of joint venture (96,718) (70,540)
 Income (loss) from operations before
 income tax and extraordinary item 367,381 86,001
 Income taxes (124,910) (53,846)
 Income before extraordinary item 242,471 32,155
 Extraordinary item: tax benefit of
 net operating loss carryforward 118,665 53,846
 NET INCOME $361,136 $86,001
 Earnings per share 0.054 0.013
 Weighted Average common
 shares outstanding 6,762,135 6,601,299
 -0- 6/17/92
 /CONTACT: John V. Hargiss, president and CEO, or Marti Bruce, controller of Biodynamics International, Inc., 813-979-0016/
 (BDYN) CO: Biodynamics International, Inc. ST: Florida IN: HEA SU: ERN


JJ-JB -- FL005 -- 1001 06/17/92 10:27 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 17, 1992
Words:505
Previous Article:VERTEX INDUSTRIES RECEIVES ORDER FOR ITS ACCESS CONTROL/ATTENDANCE SYSTEMS FOR 29 NEW YORK CITY HIGH SCHOOLS
Next Article:INTERLINK ANNOUNCES CHAIRMAN AND ADDS THREE MAJOR FINANCIAL INSTITUTIONS TO BOARD OF DIRECTORS
Topics:


Related Articles
BIODYNAMICS REPORTS RECORD NINE MONTH REVENUES AND PROFIT
BIODYNAMICS REPORTS SHARP INCREASE IN YEAR END RESULTS
BIODYNAMICS REPORTS MID-YEAR RESULTS
BIODYNAMICS THIRD QUARTER REVENUES UP 74 PERCENT
BIODYNAMICS REPORTS RESULTS FOR SHORTENED FISCAL YEAR
BIODYNAMICS REPORTS FISCAL 1994 SECOND QUARTER RESULTS
BIODYNAMICS REPORTS FISCAL 1994 3RD QUARTER RESULTS
BIODYNAMICS REPORTS FISCAL YEAR 1995 FIRST QUARTER RESULTS
BIODYNAMICS REPORTS FY 1995 SECOND QUARTER RESULTS
BIODYNAMICS REPORTS FISCAL YEAR 1996 FIRST QUARTER RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters